Andrea Zanella

Dianax (Milan, Italy) is an emerging developer, manufacturer and marketer of cost-effective, mobile in-vitro diagnostics devices to be used at the point of need. dianax ‘lab-on-a-chip’ technology puts diagnostics in the palm of your hand – literally – by working in synergy with your smartphone. To Know Now: One drop of blood could be analysed in a matter of minutes, anytime and anywhere from home to the doctor's office, expediting clinical decision-making and improving patient outcomes. The company’s breakthrough and patented BioMEMS technology is based on a series of innovations in microfluidics, electrophoresis and electrochemistry that allow laboratory-grade measurement of clinical biomarkers valuable for the screening, diagnosis and monitoring of chronic diseases. dianax is also involved in the development of rapid tests for antibiotics stewardship and other global health priorities. The dianax device has not received CE marking and U.S. Food and Drug Administration (FDA) clearance and is not commercially available yet. For more information on dianax and its products, visit www.dianax.eu or contact us at dianax@dianax.eu.

Glomeria Therapeutics is a company specialized in research and development. Our mission is to deliver hospital products, drugs and medical therapy devices to patients with severe forms of nephropathy and cardiopathy. It is Glomeria Therapeutics’ policy to keep infrastructure costs to a minimum whilst maximizing access to scientific knowledge and research in the biomedical field. Therefore, all the creative and development phases that go into identifying new therapy targets (pre-clinical pharmacology, applied engineering, prototype building, etc) are conducted in-house, while the industrial development is farmed out to service firms specialized in the target sectors. The management of Glomeria Therapeutics draws on a group of professionals with high qualification in research and development for pharmaceutical products and medical devices. As a whole the company management and scientific board can count on a solid experience in all branches of the pharmaceutics and medical apparatus.

Fremslife vuol dire Entusiasmo, Sapere, Azione, necessari per realizzare grandi imprese, realizzate da un team di professionisti in collaborazione con la ricerca scientifica, per proporre la soluzione innovativa e integrata per la terapia neurovascolare, la riabilitazione e l’imaging. Fremslife propone una soluzione innovativa e integrata per la fisioterapia e la riabilitazione funzionale attraverso percorsi terapeutico/diagnostici centrati sull’elettroceutica e la bioelettronica. Il cuore della tecnologia di Fremslife è “Frems®”, (Frequency Rhythmic Electrical Modulation System). Più nel dettaglio, Frems® è una tecnologia costituita da segnali elettrici biocompatibili generati da neurostimolatori computerizzati e somministrati attraverso elettrodi transcutanei. I segnali sono biocompatibili in quanto, a differenza dei tradizionali elettrostimolatori sono simultaneamente modulati in frequenza, ampiezza e durata, in grado quindi di interagire con i tessuti biologici. Frems® è un sistema innovativo, brevettato e certificato. E’ l’unica neuro-stimolazione scientificamente validata ad esercitare un’azione di neo-angiogenesi promuovendo il rilascio e la sintesi di fattori di crescita. Già in prima seduta agisce per ridurre il dolore. E’ ideale per trattare traumi in stato acuto, offre grande facilità di utilizzo, si integra perfettamente con altri sistemi di riabilitazione, offre una valida alternativa al trattamento farmacologico ritardando o, in numerosi casi, evitando l’intervento chirurgico. Fornisce ottimi risultati con pazienti refrattari ad altre terapie o trattamenti. Questa terapia è destinata a rivoluzionare il mondo della medicina perché può affiancare e addirittura in alcuni casi sostituire l’uso dei farmaci.

Zani&Friends-ODV is a No-Profit Volunteer Association for collecting Funds to devolve to Healthcare/Social Initiatives. Thus Zani&Friends-ODV is mainly a cultural initiative aimed at the rediscovery of a simply extraordinary, unique and unrepeatable musical era; the period of the 70s and 80s, the era of Progressive Rock, Pop and Fusion / Jazz Rock, a musical period of incredible musical creativity and innovation, a milestone in the cultural world, capable of creating, building, inventing new ways of expression and to generate profoundly evolutionary (“Progressive”) emotions, representing the essence of a world undergoing strong cultural change. Music is the Art with the highest Social and Communicative content It lends itself to being associated with initiatives of the highest value to promote their diffusion, fundraising, and organizational development in the Medical, Social Assistance, Educational and Cultural fields. Beautiful music is eternal, we must make it known to everyone. It has a huge impact on our emotions...

Dianax (Milan, Italy) is an emerging developer, manufacturer and marketer of cost-effective, mobile in-vitro diagnostics devices to be used at the point of need. dianax ‘lab-on-a-chip’ technology puts diagnostics in the palm of your hand – literally – by working in synergy with your smartphone. To Know Now: One drop of blood could be analysed in a matter of minutes, anytime and anywhere from home to the doctor's office, expediting clinical decision-making and improving patient outcomes. The company’s breakthrough and patented BioMEMS technology is based on a series of innovations in microfluidics, electrophoresis and electrochemistry that allow laboratory-grade measurement of clinical biomarkers valuable for the screening, diagnosis and monitoring of chronic diseases. dianax is also involved in the development of rapid tests for antibiotics stewardship and other global health priorities. The dianax device has not received CE marking and U.S. Food and Drug Administration (FDA) clearance and is not commercially available yet. For more information on dianax and its products, visit www.dianax.eu or contact us at dianax@dianax.eu.

Glomeria Therapeutics is a company specialized in research and development. Our mission is to deliver hospital products, drugs and medical therapy devices to patients with severe forms of nephropathy and cardiopathy. It is Glomeria Therapeutics’ policy to keep infrastructure costs to a minimum whilst maximizing access to scientific knowledge and research in the biomedical field. Therefore, all the creative and development phases that go into identifying new therapy targets (pre-clinical pharmacology, applied engineering, prototype building, etc) are conducted in-house, while the industrial development is farmed out to service firms specialized in the target sectors. The management of Glomeria Therapeutics draws on a group of professionals with high qualification in research and development for pharmaceutical products and medical devices. As a whole the company management and scientific board can count on a solid experience in all branches of the pharmaceutics and medical apparatus.

Founded in Italy in 1979 as a Management Consulting Company, Methodos is today one the most appreciated partners in organisational and cultural change management programs for many international leading companies such as: Lamborghini, Generali, FCA, Prysmian, Ducati, Sky, Vodafone, GSK, Henkel, Pirelli, Lavazza, Saipem, Medtronic, Magneti Marelli, Heineken, Credit Agricole, Deutsche Bank. Main area of activity: Cultural Change Management, Stakeholder Engagement & Internal Communication and Leadership for Change. www.methodos.com

Fremslife vuol dire Entusiasmo, Sapere, Azione, necessari per realizzare grandi imprese, realizzate da un team di professionisti in collaborazione con la ricerca scientifica, per proporre la soluzione innovativa e integrata per la terapia neurovascolare, la riabilitazione e l’imaging. Fremslife propone una soluzione innovativa e integrata per la fisioterapia e la riabilitazione funzionale attraverso percorsi terapeutico/diagnostici centrati sull’elettroceutica e la bioelettronica. Il cuore della tecnologia di Fremslife è “Frems®”, (Frequency Rhythmic Electrical Modulation System). Più nel dettaglio, Frems® è una tecnologia costituita da segnali elettrici biocompatibili generati da neurostimolatori computerizzati e somministrati attraverso elettrodi transcutanei. I segnali sono biocompatibili in quanto, a differenza dei tradizionali elettrostimolatori sono simultaneamente modulati in frequenza, ampiezza e durata, in grado quindi di interagire con i tessuti biologici. Frems® è un sistema innovativo, brevettato e certificato. E’ l’unica neuro-stimolazione scientificamente validata ad esercitare un’azione di neo-angiogenesi promuovendo il rilascio e la sintesi di fattori di crescita. Già in prima seduta agisce per ridurre il dolore. E’ ideale per trattare traumi in stato acuto, offre grande facilità di utilizzo, si integra perfettamente con altri sistemi di riabilitazione, offre una valida alternativa al trattamento farmacologico ritardando o, in numerosi casi, evitando l’intervento chirurgico. Fornisce ottimi risultati con pazienti refrattari ad altre terapie o trattamenti. Questa terapia è destinata a rivoluzionare il mondo della medicina perché può affiancare e addirittura in alcuni casi sostituire l’uso dei farmaci.